Ritonavir Completed Phase 2 Trials for Chronic Hepatitis D Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02430194Lonafarnib With Ritonavir in HDV (LOWR-2)
NCT02430181Lonafarnib With and Without Ritonavir in HDV (LOWR-1)